ModalAI, Inc. VOXL® 2 Announced as Finalist for AUVSI XCELLENCE Awards
Awards ceremony to be held at AUVSI XPONENTIAL 2023 in Denver, CO. SAN DIEGO–(BUSINESS WIRE)–#BlueUASFramework–ModalAI’s…
Awards ceremony to be held at AUVSI XPONENTIAL 2023 in Denver, CO. SAN DIEGO–(BUSINESS WIRE)–#BlueUASFramework–ModalAI’s…
LAS VEGAS–(BUSINESS WIRE)–$AP #1000_Bitcoin_Mined—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance”…
LONDON, March 13, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO…
ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
DEVON, Pa., March 13, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Engaging with more than two-thirds of key optometrists and/or ophthalmologists, and top payers on Demodex…
WALTHAM, Mass., March 13, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
— Recorded Third Quarter Revenue of $38.0 Million, a 21% Increase Compared to Prior Year…
Pivotal NAVAL-1 study of Nana-val in Epstein-Barr virus-positive (EBV+) lymphoma open at 70 sites globally;…
Achieved record sepsis product revenue and sepsis-driven T2Dx Instrument placements in 2022 LEXINGTON, Mass., March…
London, United Kingdom–(Newsfile Corp. – March 13, 2023) – TorWallet is pleased to announce the…
Jeddah, Saudi Arabia–(Newsfile Corp. – March 13, 2023) – Budget Saudi, one of the leading…
The program seeks early-stage startups for a 12-week program driving business development BOSTON & CHICAGO–(BUSINESS…
Confirmed Projects available within TechTarget’s Priority Engine provide full visibility into verified technology purchases &…
PROVIDENCE, R.I.–(BUSINESS WIRE)–Given recent market developments, Citizens has seen higher than normal interest from prospective…
PRESS RELEASE AB SCIENCE REPORTS A FIRST COMPLETE BONE MARROW RESPONSE IN A RELAPSED REFRACTORY…
PRESS RELEASE AB SCIENCE REPORTS A FIRST COMPLETE BONE MARROW RESPONSE IN A RELAPSED REFRACTORY…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Team Leading State’s First Offshore Wind Farms Plans Major New Investments in Local Jobs, Ports,…